NDM-1 Superbug Risk for Medical Tourism Patients Abroad
Author: Ian C. Langtree - Writer/Editor for Disabled World (DW)
Published: 2010/09/22 - Updated: 2026/02/13
Publication Type: Announcement
Category Topic: Medical Tourism - Related Publications
Contents: Synopsis - Introduction - Main - Insights, Updates
Synopsis: This report examines the World Health Organization's warning to medical tourists about NDM-1, a dangerous antibiotic-resistant bacteria first identified in patients returning from medical procedures in South Asia, particularly India. The information is relevant for anyone considering overseas healthcare, especially those with mobility limitations or chronic conditions who may be particularly vulnerable to post-surgical infections. Drawing on CDC research priorities and expert medical commentary, the report details three confirmed U.S. cases - all linked to medical care received in India - and explains why the bacteria's resistance to nearly all antibiotics makes it a serious global health concern. For patients with disabilities considering affordable surgical options abroad, understanding these infection risks becomes crucial when weighing cost savings against potential complications that could severely impact already-compromised health - Disabled World (DW).
Introduction
Medical Tourists Should Beware of Drug-Resistant Superbug NDM-1
The World Health Organization has issued a warning to medical travelers: let the buyer beware. This warning comes on the heels of a growing threat of an antibiotic-resistant superbug, known as the New Delhi metallo-beta-lactamase (NDM-1), named after the region in India where it was discovered.
"Many medical travelers go overseas for procedures such as hip or knee replacements, ACL surgeries, root canals and spinal fusions," explained Dr. R. Michael Koch. "However, many medical tourism patients who seek cheaper plastic or cosmetic surgeries abroad such as breast augmentation, reconstructive surgery and liposuction, may be getting more than they bargained for in the end with this superbug."
Main Content
Currently, scientists and researchers are actively trying to prevent the spread of this bug, which began as a result of plastic surgery patients carrying back this new class of superbug from South Asia to Britain. The bacteria could possibly result in a lack of supply in antibiotics specifically created for infectious diseases because of the gene's ability to become highly resistant to almost all antibiotics, according to a report in Britain's medical journal, The Lancet.
There have been three diagnosed cases of NDM-1 in the United States.
All three patients had received medical care in India, which is a country that is well known for affordable healthcare. With no new medications being developed to combat NDM-1, this antibiotic-resistant superbug could spark a global health concern. The Center for Disease Control is making research a "very high priority" and is requesting that any samples of bacteria possessing NDM-1 "be sent to CDC for further investigation."
With overseas medical tourism on the rise, American healthcare providers are trying to remain competitive in this emerging market by lowering their prices in order to be competitive. The push for domestic medical tourism could result in lower prices and quality healthcare for cosmetic surgery patients without their having to leave the United States.
"This 'superbug' is exactly the reason why we wish to keep plastic surgery patients here in New York," said Dr. Koch. "These kinds of infections just don't happen here, thanks to stringent medical regulations and standards."
Dr. Koch further advised that since surgery patients are better protected in the U.S., it should one day reduce the need to travel overseas for affordable surgery procedures.
Insights, Analysis, and Developments
Editorial Note: While medical tourism continues to attract patients seeking affordable surgical procedures, the emergence of NDM-1 highlights a hidden cost that price comparisons rarely capture. The bacteria's ability to resist conventional antibiotic treatment means that a routine cosmetic or orthopedic procedure performed overseas could transform into a life-threatening infection once patients return home, placing unexpected burdens on domestic healthcare systems. For individuals with pre-existing conditions or compromised immune systems - populations that already face elevated surgical risks - the gamble becomes even steeper. As healthcare facilities worldwide work to prevent the spread of antibiotic-resistant organisms, patients must weigh whether the financial savings of international surgery justify the potential medical consequences that no insurance policy can fully mitigate - Disabled World (DW).
Author Credentials: Ian is the founder and Editor-in-Chief of Disabled World, a leading resource for news and information on disability issues. With a global perspective shaped by years of travel and lived experience, Ian is a committed proponent of the Social Model of Disability-a transformative framework developed by disabled activists in the 1970s that emphasizes dismantling societal barriers rather than focusing solely on individual impairments. His work reflects a deep commitment to disability rights, accessibility, and social inclusion. To learn more about Ian's background, expertise, and accomplishments, visit his full biography.
Attribution/Source(s): This quality-reviewed publication was selected for publishing by the editors of Disabled World (DW) due to its relevance to the disability community. Originally authored by Disabled World and published on 2010/09/22, this content may have been edited for style, clarity, or brevity.